http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2187775-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6445 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 1995-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_168b0644d97605cc7324a8df5a5e9a3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_285a635260c75f26cc101f980e629e75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a1ed4c0edbf8f456c5adca595ef3182 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a26f7cda19503d5a366dc8a92a2b383 |
| publicationDate | 1995-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2187775-A1 |
| titleOfInvention | Method for molecular staging of prostate cancer |
| abstract | A method for enhancing the detection of prostate specific antigen in a biological sample comprising (a) extracting mRNA from the sample (b) contacting the mRNA from step (a) with reverse transcriptase under conditions allowing for the production of cDNA, (c) contacting the cDNA from step (b) with a pair of reverse transcriptase polymerase chain reaction primers capable of specifically hybridizing with DNA encoding prostate specific antigen wherein one such primer is an oligonucleotide of 12 to 30 nucleotides in length and comprises the sequence 5-CACCCATCCTA-3' and wherein the second such primer is an oligonucleotide of 12 to 30 nucleotides in length and comprises the seqnence 5'-TCCAGCCACGAC-3'; and wherein at least one of the primers is covalently linked to a modified digoxigenin molecule and under conditions allowing for extension of the primers; and (d) detecting the resulting amplified DNA. |
| priorityDate | 1994-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 473.